PriceTargets.com logo

Senseonics Holdings, Inc. Common Stock - SENS Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $18.38
  • Forecasted Upside: 175.07%
  • Number of Analysts: 6
  • Breakdown:
  • 1 Sell Ratings
  • 1 Hold Ratings
  • 3 Buy Ratings
  • 1 Strong Buy Ratings
$6.68 As of 04/10/2026 05:00 PM ET
▲ +0.01 (0.15%)

This chart shows the closing price for SENS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Senseonics Holdings, Inc. Common Stock Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SENS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SENS

Analyst Price Target is $18.38
▲ +175.07% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Senseonics Holdings, Inc. Common Stock in the last 3 months. The average price target is $18.38, with a high forecast of $31.00 and a low forecast of $9.00. The average price target represents a 175.07% upside from the last price of $6.68.

This chart shows the closing price for SENS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 6 investment analysts is to moderate buy stock in Senseonics Holdings, Inc. Common Stock. This rating has held steady since February 2026, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/17/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/15/2025
  • 1 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/15/2025
  • 1 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/14/2025
  • 2 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/12/2025
  • 2 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
1/10/2026
  • 2 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
3/11/2026
  • 1 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
4/10/2026

Latest Recommendations

  • 1 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/3/2026Stifel NicolausSet Target$9.00
2/17/2026Weiss RatingsInitiated CoverageSell (D-)
1/8/2026TD CowenReiterated RatingBuy ➝ Buy
11/6/2025HC WainwrightBoost TargetBuy ➝ Buy$18.50
11/5/2025BarclaysReiterated RatingOverweight ➝ Overweight$1.50 ➝ $31.00
11/5/2025TD CowenLower TargetBuy ➝ Buy$25.00 ➝ $15.00
10/21/2025Stifel NicolausInitiated CoverageHold$9.00
8/27/2025BarclaysInitiated CoverageOverweight$30.00
8/27/2025BarclaysInitiated CoverageOverweight$30.00
7/17/2025Lake Street CapitalUpgradeStrong-Buy
7/15/2025TD CowenInitiated CoverageBuy$25.00
7/8/2025HC WainwrightReiterated RatingBuy ➝ Buy$22.00 ➝ $28.00
6/2/2025HC WainwrightSet TargetBuy$22.00
4/10/2025MizuhoInitiated CoverageOutperform$40.00
4/9/2025MizuhoUpgradeStrong-Buy
3/5/2025HC WainwrightReiterated RatingBuy ➝ Buy$40.00 ➝ $40.00
11/15/2024HC WainwrightReiterated RatingBuy ➝ Buy$40.00 ➝ $40.00
8/14/2024HC WainwrightReiterated RatingBuy ➝ Buy$40.00 ➝ $40.00
11/14/2023HC WainwrightReiterated RatingBuy ➝ Buy$40.00
8/15/2023HC WainwrightLower TargetBuy ➝ Buy$60.00 ➝ $40.00
7/19/2023Jefferies Financial GroupInitiated CoverageUnderperform$10.00
7/25/2022HC WainwrightLower TargetBuy$120.00 ➝ $60.00
3/22/2022Colliers SecuritiesReiterated RatingBuy
8/19/2021HC WainwrightInitiated CoverageBuy$120.00
8/10/2021Colliers SecuritiesReiterated RatingBuy$80.00
(Data available from 4/10/2021 forward)

News Sentiment Rating

0.85 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/12/2025
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/12/2025
  • 1 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/11/2025
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/11/2025
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/10/2026
  • 1 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
2/9/2026
  • 0 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/11/2026
  • 6 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/10/2026

Current Sentiment

  • 6 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Senseonics Holdings, Inc. Common Stock logo
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Read More

Today's Range

Now: $6.68
Low: $6.57
High: $6.74

50 Day Range

MA: N/A

52 Week Range

Now: $6.68
Low: $5.25
High: $15.74

Volume

209,921 shs

Average Volume

352,758 shs

Market Capitalization

$279.16 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.04

Frequently Asked Questions

What sell-side analysts currently cover shares of Senseonics Holdings, Inc. Common Stock?

The following equities research analysts have issued research reports on Senseonics Holdings, Inc. Common Stock in the last twelve months: Barclays PLC, HC Wainwright, Lake Street Capital, Mizuho, Stifel Nicolaus, TD Cowen, Wall Street Zen, and Weiss Ratings.
View the latest analyst ratings for SENS.

What is the current price target for Senseonics Holdings, Inc. Common Stock?

0 Wall Street analysts have set twelve-month price targets for Senseonics Holdings, Inc. Common Stock in the last year. Their average twelve-month price target is $18.38, suggesting a possible upside of 178.6%. Barclays PLC has the highest price target set, predicting SENS will reach $31.00 in the next twelve months. Stifel Nicolaus has the lowest price target set, forecasting a price of $9.00 for Senseonics Holdings, Inc. Common Stock in the next year.
View the latest price targets for SENS.

What is the current consensus analyst rating for Senseonics Holdings, Inc. Common Stock?

Senseonics Holdings, Inc. Common Stock currently has 1 sell rating, 1 hold rating, 3 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for SENS.

What other companies compete with Senseonics Holdings, Inc. Common Stock?

Other companies that are similar to Senseonics Holdings, Inc. Common Stock include Allient, Transcat, Cytek Biosciences, Frequency Electronics and Nautilus Biotechnology. Learn More about companies similar to Senseonics Holdings, Inc. Common Stock.

How do I contact Senseonics Holdings, Inc. Common Stock's investor relations team?

Senseonics Holdings, Inc. Common Stock's physical mailing address is 20451 SENECA MEADOWS PARKWAY, GERMANTOWN, MD, 20876. The company's listed phone number is (301) 515-7260 and its investor relations email address is [email protected]. The official website for Senseonics Holdings, Inc. Common Stock is senseonics.com. Learn More about contacing Senseonics Holdings, Inc. Common Stock investor relations.